 | • レポートコード：GIR-2104Z10447 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、オキシトシン注射のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。オキシトシン注射の種類別市場規模（オキシトシン、カルベトシン）、用途別市場規模（動物用、人間用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・オキシトシン注射の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：JHP Pharmaceuticals、Grindex、Pfizer、Novartis、GSK、Bimeda、Bayer、Agrilab、Kepro B.V.、Hybio Pharmaceutical、Shanghai Hefeng、Renjian Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：オキシトシン、カルベトシン ・用途別分析2016年-2026年：動物用、人間用 ・オキシトシン注射の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・オキシトシン注射のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・オキシトシン注射のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・オキシトシン注射の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・オキシトシン注射の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Oxytocin Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Oxytocin Injection size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Oxytocin Injection market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Oxytocin Injection market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oxytocin
Carbetocin
Market segment by Application can be divided into
Animal Use
Human Use
The key market players for global Oxytocin Injection market are listed below:
JHP Pharmaceuticals
Grindex
Pfizer
Novartis
GSK
Bimeda
Bayer
Agrilab
Kepro B.V.
Hybio Pharmaceutical
Shanghai Hefeng
Renjian Pharmaceutical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Oxytocin Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oxytocin Injection Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oxytocin
1.2.3 Carbetocin
1.3 Market Analysis by Application
1.3.1 Overview: Global Oxytocin Injection Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Animal Use
1.3.3 Human Use
1.4 Global Oxytocin Injection Market Size & Forecast
1.4.1 Global Oxytocin Injection Sales in Value (2016-2026))
1.4.2 Global Oxytocin Injection Sales in Volume (2016-2026)
1.4.3 Global Oxytocin Injection Price by Type (2016-2026) & (US$/Unit)
1.5 Global Oxytocin Injection Production Capacity Analysis
1.5.1 Global Oxytocin Injection Total Production Capacity (2016-2026)
1.5.2 Global Oxytocin Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oxytocin Injection Market Drivers
1.6.2 Oxytocin Injection Market Restraints
1.6.3 Oxytocin Injection Trends Analysis
2 Manufacturers Profiles
2.1 JHP Pharmaceuticals
2.1.1 JHP Pharmaceuticals Details
2.1.2 JHP Pharmaceuticals Major Business
2.1.3 JHP Pharmaceuticals Oxytocin Injection Product and Services
2.1.4 JHP Pharmaceuticals Oxytocin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Grindex
2.2.1 Grindex Details
2.2.2 Grindex Major Business
2.2.3 Grindex Oxytocin Injection Product and Services
2.2.4 Grindex Oxytocin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Oxytocin Injection Product and Services
2.3.4 Pfizer Oxytocin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Oxytocin Injection Product and Services
2.4.4 Novartis Oxytocin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 GSK
2.5.1 GSK Details
2.5.2 GSK Major Business
2.5.3 GSK Oxytocin Injection Product and Services
2.5.4 GSK Oxytocin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Bimeda
2.6.1 Bimeda Details
2.6.2 Bimeda Major Business
2.6.3 Bimeda Oxytocin Injection Product and Services
2.6.4 Bimeda Oxytocin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Bayer
2.7.1 Bayer Details
2.7.2 Bayer Major Business
2.7.3 Bayer Oxytocin Injection Product and Services
2.7.4 Bayer Oxytocin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Agrilab
2.8.1 Agrilab Details
2.8.2 Agrilab Major Business
2.8.3 Agrilab Oxytocin Injection Product and Services
2.8.4 Agrilab Oxytocin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Kepro B.V.
2.9.1 Kepro B.V. Details
2.9.2 Kepro B.V. Major Business
2.9.3 Kepro B.V. Oxytocin Injection Product and Services
2.9.4 Kepro B.V. Oxytocin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Hybio Pharmaceutical
2.10.1 Hybio Pharmaceutical Details
2.10.2 Hybio Pharmaceutical Major Business
2.10.3 Hybio Pharmaceutical Oxytocin Injection Product and Services
2.10.4 Hybio Pharmaceutical Oxytocin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Shanghai Hefeng
2.11.1 Shanghai Hefeng Details
2.11.2 Shanghai Hefeng Major Business
2.11.3 Shanghai Hefeng Oxytocin Injection Product and Services
2.11.4 Shanghai Hefeng Oxytocin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Renjian Pharmaceutical
2.12.1 Renjian Pharmaceutical Details
2.12.2 Renjian Pharmaceutical Major Business
2.12.3 Renjian Pharmaceutical Oxytocin Injection Product and Services
2.12.4 Renjian Pharmaceutical Oxytocin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Oxytocin Injection Sales by Manufacturer
3.1 Global Oxytocin Injection Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Oxytocin Injection Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Oxytocin Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Oxytocin Injection Manufacturer Market Share
3.4.2 Top 6 Oxytocin Injection Manufacturer Market Share
3.5 Global Oxytocin Injection Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Oxytocin Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oxytocin Injection Market Size by Region
4.1.1 Global Oxytocin Injection Sales in Volume by Region (2016-2026)
4.1.2 Global Oxytocin Injection Revenue by Region (2016-2026)
4.2 North America Oxytocin Injection Revenue (2016-2026)
4.3 Europe Oxytocin Injection Revenue (2016-2026)
4.4 Asia-Pacific Oxytocin Injection Revenue (2016-2026)
4.5 South America Oxytocin Injection Revenue (2016-2026)
4.6 Middle East and Africa Oxytocin Injection Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Oxytocin Injection Sales in Volume by Type (2016-2026)
5.2 Global Oxytocin Injection Revenue by Type (2016-2026)
5.3 Global Oxytocin Injection Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Oxytocin Injection Sales in Volume by Application (2016-2026)
6.2 Global Oxytocin Injection Revenue by Application (2016-2026)
6.3 Global Oxytocin Injection Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Oxytocin Injection Sales by Type (2016-2026)
7.2 North America Oxytocin Injection Sales by Application (2016-2026)
7.3 North America Oxytocin Injection Market Size by Country
7.3.1 North America Oxytocin Injection Sales in Volume by Country (2016-2026)
7.3.2 North America Oxytocin Injection Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Oxytocin Injection Sales by Type (2016-2026)
8.2 Europe Oxytocin Injection Sales by Application (2016-2026)
8.3 Europe Oxytocin Injection Market Size by Country
8.3.1 Europe Oxytocin Injection Sales in Volume by Country (2016-2026)
8.3.2 Europe Oxytocin Injection Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Oxytocin Injection Sales by Type (2016-2026)
9.2 Asia-Pacific Oxytocin Injection Sales by Application (2016-2026)
9.3 Asia-Pacific Oxytocin Injection Market Size by Region
9.3.1 Asia-Pacific Oxytocin Injection Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Oxytocin Injection Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Oxytocin Injection Sales by Type (2016-2026)
10.2 South America Oxytocin Injection Sales by Application (2016-2026)
10.3 South America Oxytocin Injection Market Size by Country
10.3.1 South America Oxytocin Injection Sales in Volume by Country (2016-2026)
10.3.2 South America Oxytocin Injection Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oxytocin Injection Sales by Type (2016-2026)
11.2 Middle East & Africa Oxytocin Injection Sales by Application (2016-2026)
11.3 Middle East & Africa Oxytocin Injection Market Size by Country
11.3.1 Middle East & Africa Oxytocin Injection Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Oxytocin Injection Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Oxytocin Injection Typical Distributors
12.3 Oxytocin Injection Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Oxytocin Injection Revenue by Type, (USD Million), 2021-2026
Table 2. Global Oxytocin Injection Revenue by Application, (USD Million), 2021-2026
Table 3. JHP Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. JHP Pharmaceuticals Major Business
Table 5. JHP Pharmaceuticals Oxytocin Injection Product and Services
Table 6. JHP Pharmaceuticals Oxytocin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Grindex Basic Information, Manufacturing Base and Competitors
Table 8. Grindex Major Business
Table 9. Grindex Oxytocin Injection Product and Services
Table 10. Grindex Oxytocin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Oxytocin Injection Product and Services
Table 14. Pfizer Oxytocin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Novartis Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Major Business
Table 17. Novartis Oxytocin Injection Product and Services
Table 18. Novartis Oxytocin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. GSK Basic Information, Manufacturing Base and Competitors
Table 20. GSK Major Business
Table 21. GSK Oxytocin Injection Product and Services
Table 22. GSK Oxytocin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Bimeda Basic Information, Manufacturing Base and Competitors
Table 24. Bimeda Major Business
Table 25. Bimeda Oxytocin Injection Product and Services
Table 26. Bimeda Oxytocin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Bayer Basic Information, Manufacturing Base and Competitors
Table 28. Bayer Major Business
Table 29. Bayer Oxytocin Injection Product and Services
Table 30. Bayer Oxytocin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Agrilab Basic Information, Manufacturing Base and Competitors
Table 32. Agrilab Major Business
Table 33. Agrilab Oxytocin Injection Product and Services
Table 34. Agrilab Oxytocin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Kepro B.V. Basic Information, Manufacturing Base and Competitors
Table 36. Kepro B.V. Major Business
Table 37. Kepro B.V. Oxytocin Injection Product and Services
Table 38. Kepro B.V. Oxytocin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Hybio Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Hybio Pharmaceutical Major Business
Table 41. Hybio Pharmaceutical Oxytocin Injection Product and Services
Table 42. Hybio Pharmaceutical Oxytocin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Shanghai Hefeng Basic Information, Manufacturing Base and Competitors
Table 44. Shanghai Hefeng Major Business
Table 45. Shanghai Hefeng Oxytocin Injection Product and Services
Table 46. Shanghai Hefeng Oxytocin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Renjian Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Renjian Pharmaceutical Major Business
Table 49. Renjian Pharmaceutical Oxytocin Injection Product and Services
Table 50. Renjian Pharmaceutical Oxytocin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Oxytocin Injection Sales by Manufacturer (2019-2021e) & (K Units)
Table 52. Global Oxytocin Injection Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Oxytocin Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Oxytocin Injection Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Oxytocin Injection Production Site of Key Manufacturer
Table 56. Global Oxytocin Injection Sales by Region (2016-2021e) & (K Units)
Table 57. Global Oxytocin Injection Sales by Region (2021-2026) & (K Units)
Table 58. Global Oxytocin Injection Revenue by Region (2016-2021e) & (USD Million)
Table 59. Global Oxytocin Injection Revenue by Region (2021-2026) & (USD Million)
Table 60. Global Oxytocin Injection Sales by Type (2016-2021e) & (K Units)
Table 61. Global Oxytocin Injection Sales by Type (2021-2026) & (K Units)
Table 62. Global Oxytocin Injection Revenue by Type (2016-2021e) & (USD Million)
Table 63. Global Oxytocin Injection Revenue by Type (2021-2026) & (USD Million)
Table 64. Global Oxytocin Injection Price by Type (2016-2021e) & (US$/Unit)
Table 65. Global Oxytocin Injection Price by Type (2021-2026) & (US$/Unit)
Table 66. Global Oxytocin Injection Sales by Application (2016-2021e) & (K Units)
Table 67. Global Oxytocin Injection Sales by Application (2021-2026) & (K Units)
Table 68. Global Oxytocin Injection Revenue by Application (2016-2021e) & (USD Million)
Table 69. Global Oxytocin Injection Revenue by Application (2021-2026) & (USD Million)
Table 70. Global Oxytocin Injection Price by Application (2016-2021e) & (US$/Unit)
Table 71. Global Oxytocin Injection Price by Application (2021-2026) & (US$/Unit)
Table 72. North America Oxytocin Injection Sales by Country (2016-2021e) & (K Units)
Table 73. North America Oxytocin Injection Sales by Country (2021-2026) & (K Units)
Table 74. North America Oxytocin Injection Revenue by Country (2016-2021e) & (USD Million)
Table 75. North America Oxytocin Injection Revenue by Country (2021-2026) & (USD Million)
Table 76. North America Oxytocin Injection Sales by Type (2016-2021e) & (K Units)
Table 77. North America Oxytocin Injection Sales by Type (2021-2026) & (K Units)
Table 78. North America Oxytocin Injection Sales by Application (2016-2021e) & (K Units)
Table 79. North America Oxytocin Injection Sales by Application (2021-2026) & (K Units)
Table 80. Europe Oxytocin Injection Sales by Country (2016-2021e) & (K Units)
Table 81. Europe Oxytocin Injection Sales by Country (2021-2026) & (K Units)
Table 82. Europe Oxytocin Injection Revenue by Country (2016-2021e) & (USD Million)
Table 83. Europe Oxytocin Injection Revenue by Country (2021-2026) & (USD Million)
Table 84. Europe Oxytocin Injection Sales by Type (2016-2021e) & (K Units)
Table 85. Europe Oxytocin Injection Sales by Type (2021-2026) & (K Units)
Table 86. Europe Oxytocin Injection Sales by Application (2016-2021e) & (K Units)
Table 87. Europe Oxytocin Injection Sales by Application (2021-2026) & (K Units)
Table 88. Asia-Pacific Oxytocin Injection Sales by Region (2016-2021e) & (K Units)
Table 89. Asia-Pacific Oxytocin Injection Sales by Region (2021-2026) & (K Units)
Table 90. Asia-Pacific Oxytocin Injection Revenue by Region (2016-2021e) & (USD Million)
Table 91. Asia-Pacific Oxytocin Injection Revenue by Region (2021-2026) & (USD Million)
Table 92. Asia-Pacific Oxytocin Injection Sales by Type (2016-2021e) & (K Units)
Table 93. Asia-Pacific Oxytocin Injection Sales by Type (2021-2026) & (K Units)
Table 94. Asia-Pacific Oxytocin Injection Sales by Application (2016-2021e) & (K Units)
Table 95. Asia-Pacific Oxytocin Injection Sales by Application (2021-2026) & (K Units)
Table 96. South America Oxytocin Injection Sales by Country (2016-2021e) & (K Units)
Table 97. South America Oxytocin Injection Sales by Country (2021-2026) & (K Units)
Table 98. South America Oxytocin Injection Revenue by Country (2016-2021e) & (USD Million)
Table 99. South America Oxytocin Injection Revenue by Country (2021-2026) & (USD Million)
Table 100. South America Oxytocin Injection Sales by Type (2016-2021e) & (K Units)
Table 101. South America Oxytocin Injection Sales by Type (2021-2026) & (K Units)
Table 102. South America Oxytocin Injection Sales by Application (2016-2021e) & (K Units)
Table 103. South America Oxytocin Injection Sales by Application (2021-2026) & (K Units)
Table 104. Middle East & Africa Oxytocin Injection Sales by Country (2016-2021e) & (K Units)
Table 105. Middle East & Africa Oxytocin Injection Sales by Country (2021-2026) & (K Units)
Table 106. Middle East & Africa Oxytocin Injection Revenue by Country (2016-2021e) & (USD Million)
Table 107. Middle East & Africa Oxytocin Injection Revenue by Country (2021-2026) & (USD Million)
Table 108. Middle East & Africa Oxytocin Injection Sales by Type (2016-2021e) & (K Units)
Table 109. Middle East & Africa Oxytocin Injection Sales by Type (2021-2026) & (K Units)
Table 110. Middle East & Africa Oxytocin Injection Sales by Application (2016-2021e) & (K Units)
Table 111. Middle East & Africa Oxytocin Injection Sales by Application (2021-2026) & (K Units)
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Oxytocin Injection Typical Distributors
Table 115. Oxytocin Injection Typical Customers
List of Figures
Figure 1. Oxytocin Injection Picture
Figure 2. Global Oxytocin Injection Sales Market Share by Type in 2020
Figure 3. Oxytocin
Figure 4. Carbetocin
Figure 5. Global Oxytocin Injection Sales Market Share by Application in 2020
Figure 6. Animal Use
Figure 7. Human Use
Figure 8. Global Oxytocin Injection Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Oxytocin Injection Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Oxytocin Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Oxytocin Injection Sales (2016-2026) & (K Units)
Figure 30. Global Oxytocin Injection Production Capacity (2016-2026) & (K Units)
Figure 31. Global Oxytocin Injection Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Oxytocin Injection Market Drivers
Figure 33. Oxytocin Injection Market Restraints
Figure 34. Oxytocin Injection Market Trends
Figure 35. Global Oxytocin Injection Sales Market Share by Manufacturer in 2020
Figure 36. Global Oxytocin Injection Revenue Market Share by Manufacturer in 2020
Figure 37. Oxytocin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Oxytocin Injection Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Oxytocin Injection Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Oxytocin Injection Sales Market Share by Region (2016-2026)
Figure 41. Global Oxytocin Injection Revenue Market Share by Region (2016-2026)
Figure 42. North America Oxytocin Injection Revenue (2016-2026) & (USD Million)
Figure 43. Europe Oxytocin Injection Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Oxytocin Injection Revenue (2016-2026) & (USD Million)
Figure 45. South America Oxytocin Injection Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Oxytocin Injection Revenue (2016-2026) & (USD Million)
Figure 47. Global Oxytocin Injection Sales Market Share by Type (2016-2026)
Figure 48. Global Oxytocin Injection Revenue Market Share by Type (2016-2026)
Figure 49. Global Oxytocin Injection Price by Type (2016-2026) & (US$/Unit)
Figure 50. Global Oxytocin Injection Sales Market Share by Application (2016-2026)
Figure 51. Global Oxytocin Injection Revenue Market Share by Application (2016-2026)
Figure 52. Global Oxytocin Injection Price by Application (2016-2026) & (US$/Unit)
Figure 53. North America Oxytocin Injection Sales Market Share by Country (2016-2026)
Figure 54. North America Oxytocin Injection Revenue Market Share by Country (2016-2026)
Figure 55. North America Oxytocin Injection Sales Market Share by Type (2016-2026)
Figure 56. North America Oxytocin Injection Sales Market Share by Application (2016-2026)
Figure 57. Europe Oxytocin Injection Sales Market Share by Country (2016-2026)
Figure 58. Europe Oxytocin Injection Revenue Market Share by Country (2016-2026)
Figure 59. Europe Oxytocin Injection Sales Market Share by Type (2016-2026)
Figure 60. Europe Oxytocin Injection Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Oxytocin Injection Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Oxytocin Injection Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Oxytocin Injection Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Oxytocin Injection Sales Market Share by Application (2016-2026)
Figure 65. South America Oxytocin Injection Sales Market Share by Country (2016-2026)
Figure 66. South America Oxytocin Injection Revenue Market Share by Country (2016-2026)
Figure 67. South America Oxytocin Injection Sales Market Share by Type (2016-2026)
Figure 68. South America Oxytocin Injection Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Oxytocin Injection Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Oxytocin Injection Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Oxytocin Injection Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Oxytocin Injection Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界の注射用ミカファンギンナトリウム市場規模・現状・予測（2021年-2027年） Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered …- 世界の注射用ミカファンギンナトリウム市場規模・現状・予測（2021年-2027年） Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered …
- 世界のヴェノファー（鉄ショ糖注射）市場 2021：企業別、地域別、種類・用途別 The Venofer (Iron Sucrose Injection) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界のビンクリスチン硫酸塩リポソーム注射市場 2021：企業別、地域別、種類・用途別 The Vincristine Sulfate Liposome Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 世界の粉末射出成形市場規模・現状・予測（2021年-2027年） Injection Molding is a type of manufacturing technology that can use either metals or ceramics to produce small yet geometrically complex shapes that are widely used in end-user industries like the consumer products and medical devices. The adoption of leading-edge process control and monitoring sys…